| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 220.033 | 146.138 | - | - | 126.655 | 193.302 | 299.225 | 495.397 | 645.299 | 855.659 |
| Total Income - EUR | 220.259 | 146.597 | - | - | 130.003 | 193.322 | 299.236 | 496.031 | 645.299 | 855.659 |
| Total Expenses - EUR | 220.146 | 163.182 | - | - | 138.701 | 149.621 | 247.792 | 437.101 | 575.639 | 824.427 |
| Gross Profit/Loss - EUR | 113 | -16.585 | - | - | -8.699 | 43.701 | 51.445 | 58.930 | 69.660 | 31.232 |
| Net Profit/Loss - EUR | 58 | -16.585 | - | - | -9.999 | 41.768 | 48.722 | 53.984 | 63.207 | 26.235 |
| Employees | 9 | 9 | - | - | 3 | 3 | 3 | 4 | 5 | 5 |
Check the financial reports for the company - Flori Farmaceutic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 33.861 | 30.545 | - | - | 19.224 | 19.087 | 18.734 | 18.668 | 18.612 | 18.508 |
| Current Assets | 99.833 | 134.397 | - | - | 82.272 | 131.900 | 180.558 | 119.071 | 172.697 | 182.206 |
| Inventories | 54.117 | 41.740 | - | - | -9.095 | 13.123 | 42.684 | 65.045 | 129.038 | 117.557 |
| Receivables | 50.634 | 87.315 | - | - | 88.322 | 118.038 | 137.764 | 49.411 | 41.212 | 55.860 |
| Cash | -4.918 | 5.342 | - | - | 3.045 | 739 | 110 | 4.616 | 2.447 | 8.790 |
| Shareholders Funds | 32.194 | 15.281 | - | - | -40.920 | -962 | 47.780 | 101.913 | 164.811 | 190.125 |
| Social Capital | 45 | 45 | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 98.893 | 151.206 | - | - | 140.730 | 150.296 | 149.894 | 34.204 | 26.497 | 10.588 |
| Income in Advance | 3.884 | 3.844 | - | - | 3.161 | 3.101 | 3.032 | 3.042 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Flori Farmaceutic Srl